The Neuromyelitis Optica Spectrum Disorder (NMOSD) and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) Symposium for Patients and Caregivers
The in-person NMOSD and MOGAD symposium is designed to provide patients and caregivers information on the latest advancements in understanding, managing and treating NMOSD and MOGAD, while also raising awareness and enhancing patient care.
Presented by:
Andrew Sylvester, MD, Medical Director Atlantic Medical Group Comprehensive Multiple Sclerosis Center
Mark Leekoff, MD Site Director, Atlantic Medical Group Comprehensive Multiple Sclerosis Center at Bridgewater
Topics:
- Overview of NMOSD
- Features and Diagnosis of NMOSD
- Pathogenesis of NMOSD
- Optic Nerve Involvement in NMOSD
- Disease-Modifying Therapies (DMTs)
- Symptom Management in NMOSD
- NMOSD - A Patient Perspective
- Overview of MOGAD
Light refreshments will be served.
For more information please call 908-522-5686.
AGENDA
9:00 to 9:15am
Andrew Sylvester, MD, Neurologist, Atlantic Health/Mark Leekoff, MD, Neurologist, Atlantic Health
Introduction/Welcome
9:15 to 9:30 am
Andrew Sylvester, MD
Overview of Neuromyelitis Optica Center (NMO)
9:30 to 9:45am
Ashish Kapoor, MD, Neurologist, CarePoint Health Bayonne Medical Center
Features and Diagnosis of NMO
9:45 to 10:00am
Jasmin Patel, MD, Neurologist, Atlantic Health
Pathogenesis of NMO
10:00 to 10:15am
Roger Turbin MD, Neuro-Opthalmologist, UMDNJ University Hospital
Optic Nerve Involvement in NMO
10:15 to 10:30am
BREAK
10:30 to 10:50am
Mark Leekoff, MD
DMTs/ Therapeutic strategy
10:50 to 11:00am
Andrew Sylvester, MD
Symptom Management in NMO
11:00 to 11:15am
Megan Maniscalco, Patient
NMO - A Patient Perspective
11:15 to 11:30am
Andrew Sylvester, MD
MOGAD (Myelin Oligodendrocyte Glycoprotein Antibody Disease)
11:30 to 12:00pm
Panel Discussion
Limited seating. Please register by November 12, 2025